Emily Bucholz
Concepts (314)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocardial Infarction | 18 | 2024 | 1046 | 4.470 |
Why?
| | Life Expectancy | 7 | 2016 | 69 | 2.970 |
Why?
| | Patient Readmission | 11 | 2024 | 697 | 2.650 |
Why?
| | Social Class | 7 | 2024 | 282 | 2.420 |
Why?
| | Insurance, Health | 3 | 2024 | 283 | 1.440 |
Why?
| | Medicare | 6 | 2020 | 773 | 1.340 |
Why?
| | Hospitals, Pediatric | 6 | 2025 | 508 | 1.340 |
Why?
| | Heart Defects, Congenital | 8 | 2024 | 842 | 1.300 |
Why?
| | United States | 40 | 2025 | 14841 | 1.200 |
Why?
| | Health Services Accessibility | 6 | 2025 | 986 | 1.180 |
Why?
| | Medicaid | 3 | 2022 | 435 | 1.110 |
Why?
| | Data Accuracy | 3 | 2024 | 65 | 1.100 |
Why?
| | Intensive Care Units, Pediatric | 4 | 2025 | 233 | 1.100 |
Why?
| | Cardiovascular Diseases | 6 | 2022 | 2111 | 1.050 |
Why?
| | Directories as Topic | 2 | 2024 | 7 | 1.040 |
Why?
| | Insurance Carriers | 2 | 2024 | 11 | 1.030 |
Why?
| | Hypoplastic Left Heart Syndrome | 3 | 2022 | 121 | 0.960 |
Why?
| | Physicians | 2 | 2024 | 910 | 0.910 |
Why?
| | Social Determinants of Health | 6 | 2025 | 267 | 0.880 |
Why?
| | Longevity | 2 | 2024 | 165 | 0.850 |
Why?
| | Educational Status | 4 | 2024 | 470 | 0.810 |
Why?
| | Chronic Disease | 3 | 2024 | 1793 | 0.800 |
Why?
| | Nutrition Surveys | 5 | 2023 | 266 | 0.780 |
Why?
| | Data Collection | 3 | 2023 | 673 | 0.780 |
Why?
| | Male | 58 | 2025 | 67762 | 0.770 |
Why?
| | Risk Adjustment | 2 | 2022 | 78 | 0.770 |
Why?
| | Child | 32 | 2025 | 21935 | 0.770 |
Why?
| | Hospitals | 4 | 2024 | 691 | 0.770 |
Why?
| | Humans | 84 | 2025 | 137585 | 0.760 |
Why?
| | Norwood Procedures | 2 | 2023 | 29 | 0.760 |
Why?
| | Female | 61 | 2025 | 73304 | 0.760 |
Why?
| | Body Mass Index | 3 | 2016 | 2389 | 0.740 |
Why?
| | Child, Preschool | 22 | 2025 | 11074 | 0.730 |
Why?
| | Rural Population | 2 | 2025 | 563 | 0.720 |
Why?
| | Quality of Life | 4 | 2020 | 2892 | 0.720 |
Why?
| | Risk Factors | 22 | 2025 | 10388 | 0.700 |
Why?
| | General Surgery | 6 | 2012 | 173 | 0.680 |
Why?
| | Private Sector | 1 | 2020 | 52 | 0.670 |
Why?
| | Nervous System | 1 | 2020 | 67 | 0.670 |
Why?
| | Risk Assessment | 10 | 2025 | 3457 | 0.660 |
Why?
| | Residence Characteristics | 3 | 2020 | 351 | 0.620 |
Why?
| | Pediatrics | 2 | 2025 | 1101 | 0.620 |
Why?
| | Overweight | 2 | 2015 | 558 | 0.620 |
Why?
| | Ventricular Remodeling | 1 | 2021 | 266 | 0.610 |
Why?
| | Fontan Procedure | 1 | 2020 | 180 | 0.580 |
Why?
| | Stillbirth | 1 | 2018 | 72 | 0.580 |
Why?
| | Cross-Sectional Studies | 13 | 2025 | 5472 | 0.570 |
Why?
| | Length of Stay | 6 | 2024 | 1215 | 0.570 |
Why?
| | Guidelines as Topic | 1 | 2020 | 275 | 0.560 |
Why?
| | Hyperlipoproteinemia Type II | 1 | 2018 | 35 | 0.560 |
Why?
| | Statistics as Topic | 1 | 2018 | 307 | 0.560 |
Why?
| | Health Status | 2 | 2014 | 792 | 0.560 |
Why?
| | Income | 4 | 2022 | 202 | 0.560 |
Why?
| | Infant | 18 | 2025 | 9465 | 0.550 |
Why?
| | Cardiomyopathies | 1 | 2021 | 350 | 0.550 |
Why?
| | Quality Indicators, Health Care | 1 | 2020 | 307 | 0.540 |
Why?
| | Emergency Service, Hospital | 5 | 2025 | 2069 | 0.540 |
Why?
| | Hypercholesterolemia | 1 | 2018 | 106 | 0.530 |
Why?
| | Forecasting | 2 | 2015 | 389 | 0.530 |
Why?
| | Proportional Hazards Models | 6 | 2020 | 1266 | 0.520 |
Why?
| | Extracorporeal Membrane Oxygenation | 3 | 2025 | 301 | 0.510 |
Why?
| | Insurance Benefits | 1 | 2016 | 11 | 0.510 |
Why?
| | Sex Characteristics | 4 | 2016 | 762 | 0.510 |
Why?
| | Dyslipidemias | 1 | 2018 | 176 | 0.500 |
Why?
| | Frail Elderly | 2 | 2016 | 131 | 0.500 |
Why?
| | Thinness | 1 | 2016 | 91 | 0.480 |
Why?
| | Cardio-Renal Syndrome | 1 | 2015 | 12 | 0.470 |
Why?
| | Patient Admission | 2 | 2015 | 197 | 0.470 |
Why?
| | Cachexia | 1 | 2016 | 71 | 0.460 |
Why?
| | Infant, Newborn | 13 | 2025 | 6079 | 0.460 |
Why?
| | Prospective Studies | 11 | 2016 | 7604 | 0.460 |
Why?
| | Career Choice | 3 | 2011 | 219 | 0.450 |
Why?
| | Mothers | 1 | 2020 | 754 | 0.440 |
Why?
| | Postoperative Complications | 4 | 2025 | 2654 | 0.440 |
Why?
| | Hospitalization | 4 | 2025 | 2199 | 0.430 |
Why?
| | Follow-Up Studies | 7 | 2016 | 5131 | 0.430 |
Why?
| | Mortality | 2 | 2015 | 362 | 0.420 |
Why?
| | Retrospective Studies | 25 | 2025 | 15657 | 0.420 |
Why?
| | Hospital Mortality | 6 | 2024 | 911 | 0.420 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 445 | 0.420 |
Why?
| | Fever of Unknown Origin | 1 | 2013 | 12 | 0.420 |
Why?
| | Family Characteristics | 2 | 2012 | 191 | 0.420 |
Why?
| | Aged | 16 | 2025 | 23961 | 0.410 |
Why?
| | Attitude to Death | 1 | 2013 | 68 | 0.400 |
Why?
| | Heart Ventricles | 1 | 2018 | 788 | 0.390 |
Why?
| | Internship and Residency | 6 | 2012 | 1147 | 0.390 |
Why?
| | Databases, Factual | 6 | 2024 | 1357 | 0.390 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2018 | 1329 | 0.390 |
Why?
| | Patient Acceptance of Health Care | 1 | 2019 | 806 | 0.380 |
Why?
| | Smoking Cessation | 1 | 2016 | 442 | 0.380 |
Why?
| | Percutaneous Coronary Intervention | 4 | 2020 | 480 | 0.380 |
Why?
| | Women's Health | 1 | 2015 | 372 | 0.380 |
Why?
| | Clinical Clerkship | 1 | 2013 | 101 | 0.370 |
Why?
| | Loneliness | 1 | 2012 | 45 | 0.370 |
Why?
| | Obesity, Morbid | 1 | 2015 | 264 | 0.370 |
Why?
| | Adolescent | 20 | 2025 | 21513 | 0.370 |
Why?
| | Aged, 80 and over | 8 | 2025 | 7635 | 0.370 |
Why?
| | Guideline Adherence | 1 | 2016 | 556 | 0.370 |
Why?
| | Decision Making | 1 | 2018 | 900 | 0.360 |
Why?
| | Asthma | 2 | 2022 | 2295 | 0.360 |
Why?
| | Independent Living | 1 | 2012 | 105 | 0.360 |
Why?
| | Transcatheter Aortic Valve Replacement | 2 | 2025 | 130 | 0.350 |
Why?
| | Biomedical Research | 2 | 2015 | 692 | 0.350 |
Why?
| | Age Factors | 6 | 2020 | 3295 | 0.340 |
Why?
| | Young Adult | 12 | 2025 | 13209 | 0.340 |
Why?
| | Smoking | 2 | 2015 | 1627 | 0.340 |
Why?
| | Social Support | 1 | 2014 | 618 | 0.330 |
Why?
| | Time Factors | 11 | 2024 | 6828 | 0.330 |
Why?
| | Aortic Valve Stenosis | 2 | 2025 | 229 | 0.330 |
Why?
| | Cause of Death | 1 | 2012 | 434 | 0.320 |
Why?
| | Comorbidity | 3 | 2024 | 1622 | 0.310 |
Why?
| | Attitude of Health Personnel | 3 | 2012 | 1171 | 0.310 |
Why?
| | Socioeconomic Factors | 5 | 2022 | 1289 | 0.310 |
Why?
| | Sex Factors | 6 | 2025 | 2071 | 0.300 |
Why?
| | Palliative Care | 2 | 2024 | 758 | 0.290 |
Why?
| | Cohort Studies | 7 | 2024 | 5742 | 0.290 |
Why?
| | Time-to-Treatment | 3 | 2021 | 205 | 0.290 |
Why?
| | Practice Guidelines as Topic | 1 | 2016 | 1587 | 0.280 |
Why?
| | Prevalence | 4 | 2024 | 2734 | 0.280 |
Why?
| | Adult | 20 | 2024 | 37929 | 0.280 |
Why?
| | Acute Kidney Injury | 1 | 2015 | 815 | 0.270 |
Why?
| | Survival Rate | 4 | 2015 | 1972 | 0.260 |
Why?
| | Middle Aged | 14 | 2023 | 33479 | 0.260 |
Why?
| | Aftercare | 3 | 2023 | 208 | 0.240 |
Why?
| | Biomarkers | 2 | 2025 | 4149 | 0.230 |
Why?
| | Troponin | 1 | 2025 | 50 | 0.230 |
Why?
| | Obesity | 2 | 2023 | 2992 | 0.230 |
Why?
| | Thoracic Duct | 1 | 2024 | 5 | 0.230 |
Why?
| | Heart Transplantation | 3 | 2020 | 754 | 0.220 |
Why?
| | Transposition of Great Vessels | 1 | 2024 | 36 | 0.220 |
Why?
| | Heterotaxy Syndrome | 1 | 2024 | 14 | 0.220 |
Why?
| | Prognosis | 4 | 2016 | 4030 | 0.220 |
Why?
| | Tetralogy of Fallot | 1 | 2024 | 79 | 0.220 |
Why?
| | Health Status Disparities | 2 | 2019 | 289 | 0.220 |
Why?
| | Recovery of Function | 3 | 2020 | 653 | 0.210 |
Why?
| | Myocarditis | 1 | 2025 | 100 | 0.210 |
Why?
| | Healthcare Disparities | 2 | 2024 | 654 | 0.210 |
Why?
| | Kaplan-Meier Estimate | 3 | 2016 | 889 | 0.210 |
Why?
| | Self Report | 2 | 2018 | 827 | 0.210 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2018 | 2531 | 0.210 |
Why?
| | Prenatal Care | 2 | 2022 | 294 | 0.210 |
Why?
| | Specialization | 1 | 2024 | 144 | 0.200 |
Why?
| | Diet | 1 | 2011 | 1278 | 0.200 |
Why?
| | Treatment Outcome | 9 | 2024 | 10811 | 0.200 |
Why?
| | American Heart Association | 1 | 2024 | 306 | 0.200 |
Why?
| | Shock, Cardiogenic | 1 | 2023 | 63 | 0.200 |
Why?
| | Linear Models | 3 | 2020 | 849 | 0.200 |
Why?
| | Quality Improvement | 2 | 2024 | 1178 | 0.200 |
Why?
| | Medicine | 1 | 2024 | 121 | 0.190 |
Why?
| | Heart Valve Prosthesis Implantation | 2 | 2024 | 180 | 0.190 |
Why?
| | Urban Population | 1 | 2025 | 479 | 0.190 |
Why?
| | Logistic Models | 5 | 2020 | 2074 | 0.180 |
Why?
| | Hospital Units | 1 | 2021 | 29 | 0.180 |
Why?
| | Predictive Value of Tests | 2 | 2024 | 2031 | 0.180 |
Why?
| | Survival Analysis | 2 | 2016 | 1325 | 0.180 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2018 | 3715 | 0.170 |
Why?
| | Heart | 2 | 2022 | 655 | 0.170 |
Why?
| | Cardiac Surgical Procedures | 2 | 2024 | 530 | 0.170 |
Why?
| | Fetal Diseases | 1 | 2022 | 173 | 0.170 |
Why?
| | Occupations | 1 | 2020 | 49 | 0.170 |
Why?
| | Balloon Valvuloplasty | 1 | 2020 | 4 | 0.170 |
Why?
| | Pediatricians | 1 | 2022 | 129 | 0.170 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2021 | 93 | 0.170 |
Why?
| | Magnesium Sulfate | 1 | 2020 | 17 | 0.170 |
Why?
| | Respiratory Insufficiency | 1 | 2023 | 318 | 0.160 |
Why?
| | Croup | 1 | 2020 | 19 | 0.160 |
Why?
| | Decision Trees | 1 | 2020 | 93 | 0.160 |
Why?
| | Spain | 2 | 2016 | 41 | 0.160 |
Why?
| | Child Development | 2 | 2024 | 475 | 0.160 |
Why?
| | Poverty | 2 | 2015 | 521 | 0.160 |
Why?
| | Fetal Therapies | 1 | 2020 | 42 | 0.160 |
Why?
| | Mitral Valve | 1 | 2020 | 88 | 0.160 |
Why?
| | Health Expenditures | 1 | 2021 | 189 | 0.160 |
Why?
| | Reoperation | 2 | 2022 | 573 | 0.160 |
Why?
| | Gastroenteritis | 1 | 2020 | 69 | 0.150 |
Why?
| | Hypoadrenocorticism, Familial | 1 | 2018 | 1 | 0.150 |
Why?
| | Bronchopulmonary Dysplasia | 2 | 2014 | 383 | 0.150 |
Why?
| | Emergency Treatment | 1 | 2020 | 118 | 0.150 |
Why?
| | Fibrosis | 1 | 2021 | 552 | 0.150 |
Why?
| | Referral and Consultation | 2 | 2025 | 786 | 0.150 |
Why?
| | Postoperative Hemorrhage | 1 | 2019 | 86 | 0.150 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2019 | 91 | 0.150 |
Why?
| | Epidemiologic Studies | 1 | 2017 | 72 | 0.140 |
Why?
| | Developmental Disabilities | 1 | 2020 | 263 | 0.140 |
Why?
| | Ambulatory Care | 1 | 2022 | 546 | 0.140 |
Why?
| | Intensive Care Units | 1 | 2023 | 827 | 0.140 |
Why?
| | Heart Failure | 2 | 2023 | 2236 | 0.130 |
Why?
| | Cardiac Catheterization | 1 | 2020 | 530 | 0.130 |
Why?
| | Support Vector Machine | 1 | 2016 | 38 | 0.130 |
Why?
| | Stroke | 1 | 2025 | 1120 | 0.130 |
Why?
| | Incidence | 3 | 2025 | 2804 | 0.130 |
Why?
| | Respiratory Distress Syndrome, Newborn | 2 | 2014 | 106 | 0.130 |
Why?
| | Federal Government | 1 | 2016 | 28 | 0.130 |
Why?
| | Medical Records, Problem-Oriented | 1 | 2015 | 7 | 0.120 |
Why?
| | Return to Work | 1 | 2016 | 21 | 0.120 |
Why?
| | Chi-Square Distribution | 2 | 2014 | 530 | 0.120 |
Why?
| | Cholesterol, LDL | 1 | 2018 | 365 | 0.120 |
Why?
| | Documentation | 1 | 2017 | 194 | 0.120 |
Why?
| | Nutrition Assessment | 1 | 2016 | 92 | 0.120 |
Why?
| | Data Mining | 1 | 2016 | 116 | 0.120 |
Why?
| | Time | 1 | 2015 | 83 | 0.120 |
Why?
| | Sampling Studies | 1 | 2015 | 99 | 0.120 |
Why?
| | Health Surveys | 2 | 2021 | 514 | 0.120 |
Why?
| | Registries | 2 | 2024 | 2035 | 0.120 |
Why?
| | Sex Distribution | 1 | 2016 | 375 | 0.120 |
Why?
| | Thrombolytic Therapy | 1 | 2016 | 142 | 0.120 |
Why?
| | Utilization Review | 1 | 2015 | 36 | 0.120 |
Why?
| | Perception | 2 | 2015 | 359 | 0.120 |
Why?
| | Intubation, Intratracheal | 2 | 2014 | 257 | 0.110 |
Why?
| | Severity of Illness Index | 2 | 2025 | 2828 | 0.110 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2018 | 1477 | 0.110 |
Why?
| | Prescription Drugs | 1 | 2016 | 109 | 0.110 |
Why?
| | Sickness Impact Profile | 1 | 2014 | 56 | 0.110 |
Why?
| | Intermittent Positive-Pressure Ventilation | 1 | 2014 | 11 | 0.110 |
Why?
| | Infant, Extremely Low Birth Weight | 1 | 2014 | 20 | 0.110 |
Why?
| | Diffusion of Innovation | 1 | 2015 | 99 | 0.110 |
Why?
| | Geriatric Assessment | 1 | 2016 | 224 | 0.110 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2016 | 323 | 0.110 |
Why?
| | Machine Learning | 1 | 2019 | 493 | 0.110 |
Why?
| | Statistics, Nonparametric | 1 | 2014 | 431 | 0.100 |
Why?
| | Specialties, Surgical | 2 | 2011 | 75 | 0.100 |
Why?
| | Patient Outcome Assessment | 1 | 2014 | 131 | 0.100 |
Why?
| | Nutritional Status | 1 | 2016 | 350 | 0.100 |
Why?
| | Airway Extubation | 1 | 2014 | 57 | 0.100 |
Why?
| | Counseling | 1 | 2016 | 391 | 0.100 |
Why?
| | Aspirin | 1 | 2016 | 387 | 0.100 |
Why?
| | Medication Adherence | 1 | 2016 | 467 | 0.100 |
Why?
| | Patient Discharge | 3 | 2024 | 897 | 0.100 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2016 | 463 | 0.090 |
Why?
| | Professional-Family Relations | 1 | 2013 | 143 | 0.090 |
Why?
| | Quality of Health Care | 1 | 2016 | 642 | 0.090 |
Why?
| | Nutrition Policy | 1 | 2011 | 61 | 0.090 |
Why?
| | Prenatal Diagnosis | 2 | 2022 | 201 | 0.090 |
Why?
| | Student Dropouts | 1 | 2010 | 8 | 0.090 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2011 | 108 | 0.090 |
Why?
| | Birth Weight | 1 | 2014 | 516 | 0.090 |
Why?
| | Micronutrients | 1 | 2011 | 92 | 0.090 |
Why?
| | Dietary Proteins | 1 | 2011 | 135 | 0.080 |
Why?
| | Job Satisfaction | 1 | 2012 | 218 | 0.080 |
Why?
| | Self Concept | 1 | 2011 | 253 | 0.080 |
Why?
| | Algorithms | 1 | 2016 | 1704 | 0.080 |
Why?
| | Gestational Age | 3 | 2020 | 910 | 0.080 |
Why?
| | Interpersonal Relations | 1 | 2012 | 397 | 0.070 |
Why?
| | Physician-Patient Relations | 1 | 2013 | 548 | 0.070 |
Why?
| | Goals | 1 | 2010 | 170 | 0.070 |
Why?
| | China | 2 | 2020 | 217 | 0.070 |
Why?
| | Adaptation, Psychological | 1 | 2013 | 655 | 0.070 |
Why?
| | Mental Health | 1 | 2014 | 726 | 0.070 |
Why?
| | Telemedicine | 1 | 2016 | 862 | 0.070 |
Why?
| | Stress, Psychological | 1 | 2015 | 1100 | 0.060 |
Why?
| | Multivariate Analysis | 3 | 2016 | 1509 | 0.060 |
Why?
| | Wisconsin | 1 | 2025 | 101 | 0.060 |
Why?
| | Students, Medical | 1 | 2010 | 348 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2025 | 3556 | 0.060 |
Why?
| | Boston | 1 | 2024 | 91 | 0.060 |
Why?
| | Administrative Claims, Healthcare | 1 | 2024 | 26 | 0.060 |
Why?
| | Chest Pain | 1 | 2025 | 91 | 0.060 |
Why?
| | Ventricular Outflow Obstruction | 1 | 2024 | 43 | 0.060 |
Why?
| | Pulmonary Valve | 1 | 2024 | 97 | 0.050 |
Why?
| | Magnetic Resonance Imaging, Cine | 1 | 2024 | 193 | 0.050 |
Why?
| | Health Equity | 1 | 2024 | 99 | 0.050 |
Why?
| | Accelerometry | 1 | 2023 | 103 | 0.050 |
Why?
| | Neurodevelopmental Disorders | 1 | 2024 | 181 | 0.050 |
Why?
| | Surveys and Questionnaires | 2 | 2011 | 5778 | 0.050 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2024 | 238 | 0.050 |
Why?
| | Hospital Bed Capacity | 1 | 2021 | 26 | 0.050 |
Why?
| | Massachusetts | 1 | 2021 | 172 | 0.040 |
Why?
| | United States Agency for Healthcare Research and Quality | 1 | 2020 | 10 | 0.040 |
Why?
| | Ultrasonography, Prenatal | 1 | 2022 | 285 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2025 | 1946 | 0.040 |
Why?
| | Rural Health Services | 1 | 2021 | 128 | 0.040 |
Why?
| | Pregnancy | 2 | 2022 | 6763 | 0.040 |
Why?
| | Coronary Aneurysm | 1 | 2019 | 14 | 0.040 |
Why?
| | Administration, Intravenous | 1 | 2020 | 155 | 0.040 |
Why?
| | Confidence Intervals | 1 | 2020 | 329 | 0.040 |
Why?
| | Comparative Effectiveness Research | 1 | 2019 | 152 | 0.040 |
Why?
| | Patient Transfer | 1 | 2020 | 176 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2020 | 322 | 0.030 |
Why?
| | Morbidity | 1 | 2017 | 324 | 0.030 |
Why?
| | Patient Health Questionnaire | 1 | 2016 | 37 | 0.030 |
Why?
| | Nonlinear Dynamics | 1 | 2016 | 88 | 0.030 |
Why?
| | Heart Arrest | 1 | 2020 | 339 | 0.030 |
Why?
| | Research Design | 1 | 2022 | 1139 | 0.030 |
Why?
| | Drug Substitution | 1 | 2016 | 54 | 0.030 |
Why?
| | Drug Costs | 1 | 2016 | 106 | 0.030 |
Why?
| | United States Food and Drug Administration | 1 | 2016 | 208 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2020 | 1050 | 0.030 |
Why?
| | Models, Statistical | 1 | 2019 | 669 | 0.030 |
Why?
| | Drug Industry | 1 | 2016 | 111 | 0.030 |
Why?
| | Apgar Score | 1 | 2014 | 17 | 0.030 |
Why?
| | Retreatment | 1 | 2014 | 72 | 0.030 |
Why?
| | Colorado | 1 | 2024 | 4565 | 0.030 |
Why?
| | Ductus Arteriosus, Patent | 1 | 2014 | 52 | 0.030 |
Why?
| | Intracranial Hemorrhages | 1 | 2014 | 85 | 0.030 |
Why?
| | Treatment Failure | 1 | 2014 | 356 | 0.030 |
Why?
| | Coronary Artery Disease | 1 | 2019 | 698 | 0.020 |
Why?
| | Retinopathy of Prematurity | 1 | 2014 | 142 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2014 | 686 | 0.020 |
Why?
| | Disease Progression | 1 | 2020 | 2757 | 0.020 |
Why?
| | Military Facilities | 1 | 2011 | 3 | 0.020 |
Why?
| | Inflammation | 1 | 2023 | 2837 | 0.020 |
Why?
| | Medical Staff, Hospital | 1 | 2012 | 83 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2014 | 1316 | 0.020 |
Why?
| | Exercise | 1 | 2023 | 2057 | 0.020 |
Why?
| | Academic Medical Centers | 1 | 2014 | 512 | 0.020 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2014 | 257 | 0.020 |
Why?
| | Schools, Medical | 1 | 2011 | 147 | 0.020 |
Why?
| | Salaries and Fringe Benefits | 1 | 2010 | 56 | 0.020 |
Why?
| | Critical Illness | 1 | 2016 | 811 | 0.020 |
Why?
| | Community Health Services | 1 | 2011 | 227 | 0.020 |
Why?
| | Workload | 1 | 2010 | 167 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2016 | 3284 | 0.020 |
Why?
| | Depression | 1 | 2016 | 1397 | 0.020 |
Why?
| | Education, Medical, Graduate | 1 | 2010 | 486 | 0.020 |
Why?
|
|
Bucholz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|